Agbiopro Protein Degradation Hub

Agbiopro Protein Degradation Hub Overview

Protein Degradation via the ubiquitin-proteasome pathway (UPP) as a target for drug discovery is the main focus of Agbiopro Management BD IP and licensing activities. As experts in both drug discovery and business development sitting at the heart and origin of the UPP research, we are uniquely positioned to serve as a hub for UPP-related innovation and value creation. Over the last 15 years, we have accumulated invaluable specific experience in drug discovery in the ubiquitin proteasome system. Our work includes diverse modalities such as Degraders, PROTACs, GLUTACs, E3 binders, E3 inhibitors, small molecules, combination molecules, siRNAs and proprietary discovery platforms and technologies, thus making us a drug discovery hub of excellence in the ubiquitin proteasome system. We work with entrepreneurs and researchers from academia, and collaborate with industry experts to promote the discovery and development of novel therapeutics that target or manipulate components of the UPP.

Latest News

No news articles.

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Alonei Abba

Photos & Videos

No files yet

Agbiopro Protein Degradation Hub Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info